I thank all members who signed the motion and who have supported the various events that the Multiple Sclerosis Society Scotland has held this week in the Parliament. One event—for which the Presiding Officer’s permission has already been given—is for all the members who are speaking in the debate to have a picture taken in the chamber after the debate.
It has almost become a parliamentary tradition to welcome everyone to what has become known as Stacey Adam’s MS awareness week debate. As everybody knows, I am involved with the MS Society Scotland because my wife battles with the condition every day of her life. I say that she “battles” and not “suffers” with MS, because those with MS do not class themselves as sufferers; they tend to battle on. People in the MS community, as a rule, tend to be very positive about how they go about things. The fact that they tend not to moan can make a difficulty for the MS community because, as we politicians know, those who shout the loudest and moan the most tend to get the most. However, what is important is that people in the MS community are proactive and get on with their lives, because they know that life is far too short.
When I first met Stacey, she said that she was going to live every day as if it were her last. Some might think that that is a negative attitude, but it is not, because she drives herself forward every day and MS has never stopped her doing anything. Those in Parliament who have worked with her over the years have seen that nothing will stop her.
Ironically, many people do not see the scooter, wheelchair or mobility aids that Stacey uses; they see Stacey and her personality. She is a force of nature; when she wants something, she makes sure that she gets it—after 22 years of marriage, that can get quite challenging at times. It is not just Stacey, though—people who live with MS, and their families, think that way. There are many of them, because multiple sclerosis affects more than 11,000 people in Scotland and more than 100,000 in the United Kingdom.
Symptoms usually start in a person’s 20s or 30s, which are the key working years, and that is sometimes when they get a diagnosis. Stacey was diagnosed at 16, but that might be more to do with her health professional mother, who decided that she was going to find out immediately what the issue was and what her daughter had to deal with.
Three times as many women as men have MS. In people who have MS, the coating—or myelin—around their nerve fibres is damaged. Nobody with MS has exactly the same symptoms, which causes difficulty when people try to deal with the condition.
At present, there are 13 disease-modifying therapies in Scotland that are licensed through the national health service. Other treatments are coming through, but there is an on-going issue with profiteering by some pharmaceutical companies. At the event that we held last night, I spoke to a number of neurology consultants who gave me examples of a drug that, when used for other conditions or diseases cost, say, £1,000 per treatment. One neurologist asked me how much I thought the same drug cost when made and used for MS. I said that it would be around £5,000 or something, but he said that it was £50,000. Many pharmaceutical companies profit from people’s conditions; licensed products should not cost the amount that they cost.
If people are looking at the issue and talking to pharmaceutical companies, they should question them on it, because the practice must stop. People should not be fooled by the argument of some pharmaceutical companies that they research the drugs and that they must pass on the cost of that. In many cases, that is simply not the case. Such drugs were developed many years ago and are now used for another reason. The problem is that the companies pitch the price far too high for things that could make a difference to the lives of many people dealing with MS.
However, one of the good things that we heard last night was when Professor Chandran from the University of Edinburgh said that Scotland has a strong record on research, on which we must build. He also commended the Scottish Government for its investment in various research programmes and tried to encourage the MS Society to invest in one particular programme, on the basis that the Scottish Government is already investing in it. The MS Society currently funds 10 research projects in Scotland, with an investment of more than £350 million.
There is an on-going debate within the MS community about the role that vitamin D might play in MS. At the University of Edinburgh, Dr Anne Astier’s project aims to find out how immune cells move from the brain into the spinal cord, where they can cause damage, and whether vitamin D is involved in that process. That might explain why, per head of population, we have more people with multiple sclerosis than anywhere else. Dr Astier said that
“MS is a very complicated condition, with a number of factors determining whether you might get the condition.”
She added that
“It is thought that one of those factors is vitamin D, which might play a role in why prevalence in Scotland is so high.”
We must continue with that work because, although many disease-modifying treatments are available, we must take the research to a stage at which we know exactly how to tackle the disease.
Yesterday, Professor Chandran said that he wants to get to a stage with MS that is similar to when someone is diagnosed with cancer, so that doctors can say, “This is the type that you have got, this is how we will treat it and this is how it will affect you.” In the past, people with MS have never had a plan for how they can cope with their disease. The MS Society has decided to embark on a campaign, which it will launch later in the year, to raise £100 million to ensure that we can fund more of that type of research, so that people and families who are dealing with multiple sclerosis have the opportunity to hope for a better future.
We can find a cure for the condition and we can ensure that those who are living with it have better opportunities in life. Members have all met Stacey; they know what she is like. I often wonder what, in a world without MS, that incredible force of nature would have achieved. Paisley and I are lucky, because I have a partner who supports me, works with me in the Parliament and represents my constituents and me. In Paisley, we have two MSPs for the price of one.
Let us think about that world with no MS; together, we can rid the world of multiple sclerosis.
18:23